{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:51:22Z","timestamp":1792165882852,"version":"4.4.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-025-03124-z","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T05:16:40Z","timestamp":1749446200000},"page":"955-961","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Direct oral anticoagulants as secondary prophylaxis of venous thromboembolism in paroxysmal nocturnal hemoglobinuria: an Italian monocentric experience"],"prefix":"10.1007","volume":"58","author":[{"given":"M.","family":"Biglietto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L.","family":"Faccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Micozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Antonacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U. La","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. P.","family":"Iori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Chistolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"issue":"10","key":"3124_CR1","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1182\/blood.2019003812","volume":"137","author":"RA Brodsky","year":"2021","unstructured":"Brodsky RA (2021) How I treat paroxysmal nocturnal hemoglobinuria. Blood 137(10):1304\u20131309. https:\/\/doi.org\/10.1182\/blood.2019003812","journal-title":"Blood"},{"issue":"6","key":"3124_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-2141.2011.08690.x","volume":"153","author":"L Luzzatto","year":"2011","unstructured":"Luzzatto L, Gianfaldoni G, Notaro R (2011) Management of paroxysmal nocturnal haemoglobinuria: a personal view. Br J Haematol 153(6):709\u2013720. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08690.x","journal-title":"Br J Haematol"},{"issue":"25","key":"3124_CR3","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1182\/blood-2012-09-311381","volume":"121","author":"A Hill","year":"2013","unstructured":"Hill A, Kelly RJ, Hillmen P (2013) Thrombosis in paroxysmal nocturnal hemoglobinuria. Blood 121(25):4985\u20134996 quiz 5105. https:\/\/doi.org\/10.1182\/blood-2012-09-311381","journal-title":"Blood"},{"issue":"10","key":"3124_CR4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.20452\/pamw.4333","volume":"128","author":"MK Mimier","year":"2018","unstructured":"Mimier MK, Janczak DT, McBane RD, Houghton DE, Wysokinski WE (2018) Thrombosis of atypical location: how to treat patients in the era of direct oral anticoagulants? Pol Arch Intern Med 128(10):604\u2013608. https:\/\/doi.org\/10.20452\/pamw.4333","journal-title":"Pol Arch Intern Med"},{"issue":"9027","key":"3124_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/s0140-6736(95)12360-1","volume":"348","author":"G Soci\u00e9","year":"1996","unstructured":"Soci\u00e9 G, Mary JY, de Gramont A, Rio B, Leporrier M, Rose C, Heudier P, Rochant H, Cahn JY, Gluckman E (1996) Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French society of haematology. Lancet 348(9027):573\u2013577. https:\/\/doi.org\/10.1016\/s0140-6736(95)12360-1","journal-title":"Lancet"},{"issue":"8","key":"3124_CR6","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1182\/blood-2008-01-133918","volume":"112","author":"RP de Latour","year":"2008","unstructured":"de Latour RP, Mary JY, Salanoubat C, Terriou L, Etienne G, Mohty M, Roth S, de Guibert S, Maury S, Cahn JY, Soci\u00e9 G (2008) French society of hematology; French association of young hematologists. Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood 112(8):3099\u20133106. https:\/\/doi.org\/10.1182\/blood-2008-01-133918","journal-title":"Blood"},{"issue":"7","key":"3124_CR7","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00277-020-04052-z","volume":"99","author":"H Schrezenmeier","year":"2020","unstructured":"Schrezenmeier H, R\u00f6th A, Araten DJ, Kanakura Y, Larratt L, Shammo JM, Wilson A, Shayan G, Maciejewski JP (2020) Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the international PNH registry. Ann Hematol 99(7):1505\u20131514. https:\/\/doi.org\/10.1007\/s00277-020-04052-z","journal-title":"Ann Hematol"},{"issue":"11","key":"3124_CR8","doi-asserted-by":"publisher","first-page":"e2350817","DOI":"10.1002\/eji.202350817","volume":"54","author":"CQ Schmidt","year":"2024","unstructured":"Schmidt CQ, H\u00f6chsmann B, Schrezenmeier H (2024) The complement model disease paroxysmal nocturnal hemoglobinuria. Eur J Immunol 54(11):e2350817. https:\/\/doi.org\/10.1002\/eji.202350817","journal-title":"Eur J Immunol"},{"key":"3124_CR9","doi-asserted-by":"publisher","first-page":"101158","DOI":"10.1016\/j.blre.2023.101158","volume":"64","author":"A Waheed","year":"2024","unstructured":"Waheed A, Shammo J, Dingli D (2024) Paroxysmal nocturnal hemoglobinuria: review of the patient experience and treatment landscape. Blood Rev 64:101158. https:\/\/doi.org\/10.1016\/j.blre.2023.101158","journal-title":"Blood Rev"},{"issue":"4","key":"3124_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/ajh.24278","volume":"91","author":"M Loschi","year":"2016","unstructured":"Loschi M, Porcher R, Barraco F, Terriou L, Mohty M, de Guibert S, Mahe B, Lemal R, Dumas PY, Etienne G, Jardin F, Royer B, Bordessoule D, Rohrlich PS, Fornecker LM, Salanoubat C, Maury S, Cahn JY, Vincent L, Sene T, Rigaudeau S, Nguyen S, Lepretre AC, Mary JY, Corront B, Socie G (2016) Peffault de Latour R. Impact of Eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study. Am J Hematol 91(4):366\u2013370. https:\/\/doi.org\/10.1002\/ajh.24278","journal-title":"Am J Hematol"},{"issue":"12","key":"3124_CR11","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1182\/blood-2007-06-095646","volume":"110","author":"P Hillmen","year":"2007","unstructured":"Hillmen P, Muus P, D\u00fchrsen U, Risitano AM, Schubert J, Luzzatto L, Schrezenmeier H, Szer J, Brodsky RA, Hill A, Soci\u00e9 G, Bessler M, Rollins SA, Bell L, Rother RP, Young NS (2007) Effect of the complement inhibitor Eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood 110(12):4123\u20134128. https:\/\/doi.org\/10.1182\/blood-2007-06-095646","journal-title":"Blood"},{"issue":"3","key":"3124_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/jth.12485","volume":"12","author":"T van der Hulle","year":"2014","unstructured":"van der Hulle T, Kooiman J, den Exter PL, Dekkers OM, Klok FA, Huisman MV (2014) Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemost 12(3):320\u2013328. https:\/\/doi.org\/10.1111\/jth.12485","journal-title":"J Thromb Haemost"},{"issue":"2","key":"3124_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1182\/blood.2024023988","volume":"144","author":"C Gurnari","year":"2024","unstructured":"Gurnari C, Awada H, Pagliuca S, Dima D, Ullah F, Kawashima N, Kubota Y, Colak C, Visconte V, Patel BJ, Dhillon V, Marneni N, Balasubramanian SK, Kishtagari A, Bat T, Maciejewski JP (2024) Paroxysmal nocturnal hemoglobinuria-related thrombosis in the era of novel therapies: a 2043-patient-year analysis. Blood 144(2):145\u2013155. https:\/\/doi.org\/10.1182\/blood.2024023988","journal-title":"Blood"},{"issue":"11","key":"3124_CR14","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/jth.13140","volume":"13","author":"S Kaatz","year":"2015","unstructured":"Kaatz S, Ahmad D, Spyropoulos AC, Schulman S, Subcommittee on Control of Anticoagulation (2015) Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost 13(11):2119\u20132126. https:\/\/doi.org\/10.1111\/jth.13140","journal-title":"J Thromb Haemost"},{"issue":"36","key":"3124_CR15","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, De Potter TJR, Dwight J, Guasti L, Hanke T, Jaarsma T, Lettino M, L\u00f8chen ML, Lumbers RT, Maesen B, M\u00f8lgaard I, Rosano GMC, Sanders P, Schnabel RB, Suwalski P, Svennberg E, Tamargo J, Tica O, Traykov V, Tzeis S, Kotecha D, ESC Scientific Document Group (2024) 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European association for Cardio-Thoracic surgery (EACTS). Eur Heart J 45(36):3314\u20133414. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176","journal-title":"Eur Heart J"},{"issue":"10","key":"3124_CR16","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","volume":"78","author":"MG Tektonidou","year":"2019","unstructured":"Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, Cuadrado MJ, D\u00f6rner T, Ferrer-Oliveras R, Hambly K, Khamashta MA, King J, Marchiori F, Meroni PL, Mosca M, Pengo V, Raio L, Ruiz-Irastorza G, Shoenfeld Y, Stojanovich L, Svenungsson E, Wahl D, Tincani A, Ward MM (2019) EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 78(10):1296\u20131304. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215213","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3124_CR17","doi-asserted-by":"publisher","first-page":"E59","DOI":"10.1002\/ajh.26414","volume":"97","author":"GF Gerber","year":"2022","unstructured":"Gerber GF, DeZern AE, Chaturvedi S, Brodsky RA (2022) A 15-year, single institution experience of anticoagulation management in paroxysmal nocturnal hemoglobinuria patients on terminal complement Inhibition with history of thromboembolism. Am J Hematol 97(2):E59\u2013E62. https:\/\/doi.org\/10.1002\/ajh.26414","journal-title":"Am J Hematol"},{"issue":"Suppl 1","key":"3124_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/ijlh.14281","volume":"46","author":"F Versino","year":"2024","unstructured":"Versino F, Fattizzo B (2024) Complement Inhibition in paroxysmal nocturnal hemoglobinuria: from biology to therapy. Int J Lab Hematol 46(Suppl 1):43\u201354. https:\/\/doi.org\/10.1111\/ijlh.14281","journal-title":"Int J Lab Hematol"},{"key":"3124_CR19","doi-asserted-by":"publisher","unstructured":"Bosi A, Barcellini W, Fattizzo B (2022) Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia. Thromb J.; 20(1): 46. https:\/\/doi.org\/10.1186\/s12959-022-00407-w Erratum in: Thromb J 2022;20(1):51","DOI":"10.1186\/s12959-022-00407-w"},{"key":"3124_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.thromres.2024.04.018","volume":"238","author":"G Palareti","year":"2024","unstructured":"Palareti G, Legnani C, Tosetto A, Poli D, Testa S, Ageno W, Pengo V, Cosmi B, Prandoni P (2024) D-dimer and risk of venous thromboembolism recurrence: comparison of two studies with similar designs but different laboratory and clinical results. Thromb Res 238:52\u201359. https:\/\/doi.org\/10.1016\/j.thromres.2024.04.018Epub 2024 Apr 18","journal-title":"Thromb Res"},{"issue":"2","key":"3124_CR21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1182\/blood-2014-01-548065","volume":"124","author":"G Palareti","year":"2014","unstructured":"Palareti G, Cosmi B, Legnani C, Antonucci E, De Micheli V, Ghirarduzzi A, Poli D, Testa S, Tosetto A, Pengo V, Prandoni P (2014) DULCIS (D-dimer and ultrasonography in combination Italian Study) investigators. D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study. Blood 124(2):196\u2013203. https:\/\/doi.org\/10.1182\/blood-2014-01-548065Epub 2014 May 30","journal-title":"Blood"},{"issue":"23","key":"3124_CR22","doi-asserted-by":"publisher","first-page":"6005","DOI":"10.1182\/bloodadvances.2022007973","volume":"6","author":"G Palareti","year":"2022","unstructured":"Palareti G, Poli D, Ageno W, Legnani C, Antonucci E, Bucherini E, Testa S, Paoletti O, Chistolini A, Serrao A, Martinelli I, Bucciarelli P, Falanga A, Tosetto A, Sarti L, Mastroiacovo D, Cosmi B, Vison\u00e0 A, Santoro RC, Zanatta N, Grandone E, Bert\u00f9 L, Pengo V, Caiano L, Prandoni P (2022) D-dimer and reduced-dose Apixaban for extended treatment after unprovoked venous thromboembolism: the apidulcis study. Blood Adv 6(23):6005\u20136015. https:\/\/doi.org\/10.1182\/bloodadvances.2022007973","journal-title":"Blood Adv"},{"issue":"8","key":"3124_CR23","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1182\/bloodadvances.2023012408","volume":"8","author":"S Testa","year":"2024","unstructured":"Testa S, Palareti G, Legnani C, Dellanoce C, Cini M, Paoletti O, Ciampa A, Antonucci E, Poli D, Morandini R, Tala M, Chiarugi P, Santoro RC, Iannone AM, De Candia E, Pignatelli P, Faioni EM, Chistolini A, Esteban MDP, Marietta M, Tripodi A, Tosetto A (2024) Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study. Blood Adv 8(8):1846\u20131856. https:\/\/doi.org\/10.1182\/bloodadvances.2023012408","journal-title":"Blood Adv"},{"issue":"18","key":"3124_CR24","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1182\/bloodadvances.2024013126","volume":"8","author":"G Palareti","year":"2024","unstructured":"Palareti G, Testa S, Legnani C, Dellanoce C, Cini M, Paoletti O, Ciampa A, Antonucci E, Poli D, Morandini R, Tala M, Chiarugi P, Santoro RC, Iannone AM, De Candia E, Pignatelli P, Faioni EM, Chistolini A, Esteban MDP, Marietta M, Tripodi A, Tosetto A (2024) More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study. Blood Adv 8(18):4913\u20134923. https:\/\/doi.org\/10.1182\/bloodadvances.2024013126","journal-title":"Blood Adv"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03124-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-025-03124-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03124-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T09:27:47Z","timestamp":1762939667000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-025-03124-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":24,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["3124"],"URL":"https:\/\/doi.org\/10.1007\/s11239-025-03124-z","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"28 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}